Exparel Infiltration in Anterior Cruciate Ligament Reconstruction
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single blinded, standard of care controlled clinical trial. All adult
patients over sixteen desiring anterior cruciate ligament reconstruction will be eligible.
The study compares pain control and opioid consumption in patients undergoing ACL
reconstruction between patients receiving liposomal bupivacaine and those who underwent a
preoperative femoral nerve block.